Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations.
Saved in:
| Title: | Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations. |
|---|---|
| Authors: | Greter H; Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland., Ivol S; Janssen Vaccines & Prevention B.V, Archimedesweg 4, 2333 CN Leiden, Netherlands., Oriol Mathieu V; Janssen Vaccines & Prevention B.V, Archimedesweg 4, 2333 CN Leiden, Netherlands., Erismann S; Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland., Prytherch H; Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland., Steinmann P; Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland. Electronic address: Peter.steinmann@swisstph.ch. |
| Source: | Vaccine [Vaccine] 2021 Jan 15; Vol. 39 (3), pp. 580-587. Date of Electronic Publication: 2020 Dec 18. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
